CClinicalTrials.gg
RecruitingNCT05309473Updated Apr 23, 2024

Acoustic Stimulation During Restricted Sleep After Sleep Deprivation

An interventional study of Philips SmartSleep Acoustic Stimulation Device and Sham (no Acoustic Stimulation) in Sleep Deprivation, Sleep Restriction and Acoustic Stimulation, sponsored by Walter Reed Army Institute of Research (WRAIR). Recruiting at 1 site in United States. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-23.

Sponsored by Walter Reed Army Institute of Research (WRAIR) · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 39 Years
Sex
All
01

Study summary

The purpose of this study is to determine if brief sounds or tones presented within a restricted period of recovery sleep after a period of sleep deprivation will enhance restorative properties and improve performance during a subsequent period of wakefulness.

02

Conditions studied

  • Sleep Deprivation
  • Sleep Restriction
  • Acoustic Stimulation
  • Performance
  • Alertness

Browse trials for

03

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy men and non-pregnant, non-lactating women 18 to 39 years of age (inclusive)
  • Must demonstrate adequate comprehension of the protocol, by achieving a score of at least 80% correct on a short multiple-choice quiz. Individuals who fail to achieve a passing score on the initial quiz will be given one opportunity to retest after a review of protocol information. Individuals who fail the comprehension assessment for the second time will be disqualified.

Exclusion criteria

Exclusion Criteria:

  • You must have learned English as your first language
  • You must have a body mass index (BMI) below 30 (this is a mathematical calculation of your height and weight)
  • You must not have current or a history of sleeping problems (for example, insomnia or sleep apnea), or symptoms that indicate a potential sleep disorder
  • You must get an average of 6-9 hours of sleep per night and maintain a normal sleep/wake schedule
  • You must not drink excessive amounts of caffeine, alcohol, or smoke cigarettes regularly
  • You must not be on certain medications (determined on a case by case basis)
  • You must test negative for illicit drugs
  • Women must not be pregnant or nursing
  • You must not be participating in another ongoing clinical trial
  • You must have a social security number or tax identification number in order to be paid for screening and participation in the study
  • You cannot have a history of the following conditions: Cardiovascular disease, a neurologic disorder, pulmonary disease requiring inhaler use, kidney disease or kidney abnormalities, liver disease of liver abnormalities, a history of psychiatric disorder requiring hospitalization or medication within the last two years or for a continuous period of more than 6 months in the last ten years
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Subjects Who Received Acoustic Stimulation

    Following 40 hours of deprivation participants will sleep for approximately a four hour recovery sleep period and receive acoustic stimulation via the Philips SmartSleep during slow-wave sleep. They will then sleep for second night of four hour recovery sleep and receive acoustic stimulation via the Philips Smart Sleep device during slow-wave sleep again.

    Device: Philips SmartSleep Acoustic Stimulation Device

  • Sham comparator
    Subjects Who Received Sham (no Acoustic Stimulation)

    Following 40 hours of deprivation participants will sleep for approximately a four hour recovery sleep period and receive Sham (no acoustic stimulation) via the Philips SmartSleep during slow-wave sleep. They will then sleep for second night of four hour recovery sleep and receive Sham (no acoustic stimulation) via the Philips Smart Sleep device during slow-wave sleep again.

    Device: Sham (no Acoustic Stimulation)

Interventions

  • DevicePhilips SmartSleep Acoustic Stimulation Device

    Prior to bedtime on the first two recovery nights, a Philips SmartSleep device will be applied to the head of each subject. Subjects will receive acoustic stimulation during the four hours of sleep.

  • DeviceSham (no Acoustic Stimulation)

    Prior to bedtime on the first two recovery nights, a Philips SmartSleep device will be applied to the head of each subject. Subjects will receive Sham (no acoustic stimulation) during the four hours of sleep.

05

What researchers measure

Primary outcomes

  1. Measure the effects of sleep deprivation/sleep restriction on performance using the Psychomotor Vigilance Task (PVT)

    Performed at approximately 75 minutes intervals throughout the sleep deprivation and recovery days

    Time frame: 8 days

Secondary outcomes

  1. Measure simple arithmetic processing using the Mathematical Processing Subtest of the Automated Neuropsychological Assessment Metrics 4 (ANAM4)

    Computer based series of mathematical calculations

    Time frame: 5 days

  2. Measure current mood states using the Mood Analogue Scale (MAS)

    Computer based self adjective checklist of measure mood states

    Time frame: 5 days

  3. Measure latency to sleep using the Maintenance of Wakefulness Test (MWT)

    Subjects will be escorted to their individual darkened, sound-attenuated bedrooms and allowed to lie down on their beds. They will be instructed to close their eyes and try to remain awake. Polysomnography will be monitored online.

    Time frame: 5 days

  4. Measure alertness using the Karolinska Sleepiness Scale (KSS)

    Computer based self rated level of sleepiness

    Time frame: 5 days

  5. Measure various aspects of mood using the Walter Reed Army Institute of Research (WRAIR) Mood Battery

    Computer based battery testing various aspects of mood

    Time frame: 5 days

  6. Measure various aspects of Sleep and Wakefulness using Polysomnographic measurements with video

    Sleep will be measured during the night using polysomnography

    Time frame: 5 days

  7. Measure various aspects of Sleep and Wakefulness using Actigraphy

    A watch-like device called an actigraph will measure movement to determine wake and sleep

    Time frame: 22 days

06

Study locations

1 of 1 sites recruiting
07

Registry details

Key details

Study ID
NCT05309473
Lead sponsor
Walter Reed Army Institute of Research (WRAIR)
Collaborators
Philips Healthcare
Responsible party
JOHN D. HUGHES (Neurologist, Walter Reed Army Institute of Research (WRAIR)) — Principal investigator
First posted
Apr 4, 2022
Start date
Mar 14, 2022
Primary completion
Oct 2025 (estimated)
Completion
Oct 2026 (estimated)
Last update
Apr 23, 2024

Study contacts

John D Hughes, MD
Contact
john.d.hughes4.ctr@mail.mil
301-319-3214

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion